First Trust Advisors LP Boosts Position in Synopsys, Inc. $SNPS

First Trust Advisors LP lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 46.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 270,496 shares of the semiconductor company’s stock after buying an additional 85,625 shares during the quarter. First Trust Advisors LP’s holdings in Synopsys were worth $107,246,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Sankala Group LLC acquired a new position in Synopsys in the fourth quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Synopsys during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys during the fourth quarter worth about $28,000. Atlas Capital Advisors Inc. acquired a new stake in shares of Synopsys during the fourth quarter worth about $32,000. Finally, Geneos Wealth Management Inc. lifted its stake in Synopsys by 151.5% in the first quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Price Performance

Synopsys stock opened at $373.47 on Friday. The business has a 50 day simple moving average of $456.13 and a 200-day simple moving average of $455.25. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The stock has a market capitalization of $71.51 billion, a PE ratio of 86.45, a price-to-earnings-growth ratio of 2.19 and a beta of 1.22.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the previous year, the company posted $3.67 EPS. Synopsys’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Benchmark assumed coverage on shares of Synopsys in a research report on Wednesday, July 15th. They set a “buy” rating and a $570.00 target price on the stock. Rosenblatt Securities upped their price target on shares of Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research report on Tuesday, May 26th. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research note on Thursday, May 28th. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Finally, Bank of America lifted their price objective on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and an average target price of $570.06.

Insider Activity

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company’s stock.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.